Corbus Pharmaceuticals Holdings, Inc. ( CRBP) Discusses Phase 1a Single-Ascending and Multiple-Ascending Dose Data December 11, 2025 8:00 AM EST ...
Introduction The COVID-19 pandemic is expected to have impacted many drivers of antimicrobial resistance (AMR) and compounded ...
Objective The objective of this study is to assess the association between childhood exposure to pets and farm animals and ...
Dec 8 (Reuters) - The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed to help ...
The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their ...
Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...
By Kamal Choudhury Dec 3 (Reuters) - Excelsior Sciences said on Wednesday it has raised $95 million to develop technology ...
Biphenomycins, natural products derived from bacteria, show excellent antimicrobial activity, but have long remained out of ...
Clinical trials for drug development are notoriously slow and expensive, and only a small fraction of drug candidates end up being approved by the regulatory authorities. The extensive bottlenecks in ...
New York startup to use new chemistry process, AI and robotics to make drug compounds in the U.S.
7don MSN
Common aldehydes transformed by light could accelerate drug discovery and material development
A new chemical method that could speed up the creation of medicines, materials and products people rely on every day has been ...
Diabetes goes beyond just glucose control, and recent advancements in research are enhancing drug development for the disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback